YD Bio Stock (NASDAQ:YDES)
Previous Close
$12.96
52W Range
$5.30 - $25.00
50D Avg
$14.35
200D Avg
$14.85
Market Cap
$913.96M
Avg Vol (3M)
$84.84K
Beta
0.12
Div Yield
-
YDES Company Profile
Breeze Holdings Acquisition Corp. operates as a clinical-stage biopharmaceutical company focuses on cancer prevention medical diagnostics and the development of exosome-based therapeutics with the potential to transform the treatment of a diseases with unmet medical need. The company is based in Taipei, Taiwan.